Government news, all in one place

Medicines and Healthcare products Regulatory Agency

787 articles

Showing 31-60

Patient and family experiences inform antidepressant safety information review

Patient and family experiences inform antidepressant safety information review

Monday, 01 December 2025

An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients ...

Read More → news_story
From Brussels sprouts to mobility scooters: five tips from the MHRA for staying safe and well over the festive period

From Brussels sprouts to mobility scooters: five tips from the MHRA for staying safe and well over the festive period

Monday, 01 December 2025

The MHRA has five top tips to help you stay well through the festive season and beyond...

Read More → press_release
New MHRA supported research reveals patterns of vaccine derived poliovirus spread and implications for global eradication efforts

New MHRA supported research reveals patterns of vaccine derived poliovirus spread and implications for global eradication efforts

Thursday, 27 November 2025

Study provides crucial insights for targeting rapid response strategies and improving polio surveillance worldwide ...

Read More → press_release
MHRA and NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies

MHRA and NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies

Thursday, 27 November 2025

Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supportin...

Read More → press_release
MHRA approves inavolisib for the treatment of breast cancer

MHRA approves inavolisib for the treatment of breast cancer

Wednesday, 26 November 2025

The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive ...

Read More → press_release
Three convicted in major MHRA investigation into illegal online supply of medicines

Three convicted in major MHRA investigation into illegal online supply of medicines

Tuesday, 25 November 2025

Operation Lamborghini disrupts multimillion-pound criminal network supplying controlled drugs and unauthorised medicines online ...

Read More → press_release
MHRA reaffirms safety of childhood vaccination

MHRA reaffirms safety of childhood vaccination

Monday, 24 November 2025

Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases...

Read More → news_story
Professor Alastair Denniston: The future regulation of AI in healthcare

Professor Alastair Denniston: The future regulation of AI in healthcare

Wednesday, 19 November 2025

Creating a framework that is safe, fast and trusted....

Read More → news_story
MHRA led study reveals major inconsistencies in global microbiome research

MHRA led study reveals major inconsistencies in global microbiome research

Tuesday, 11 November 2025

International collaboration establishes new quality standards to improve reliability of gut health studies – improving accuracy to provide better diag...

Read More → news_story
Dr Alison Cave: Pharmacists are on the frontline of medicines safety – and your reports make all the difference

Dr Alison Cave: Pharmacists are on the frontline of medicines safety – and your reports make all the difference

Friday, 07 November 2025

As part of #MedSafetyWeek, the MHRA’s Chief Safety Officer reflects in The Pharmacist on the vital role pharmacists play in keeping medicines and med...

Read More → news_story
MHRA approves Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis infection, including disease

MHRA approves Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis infection, including disease

Thursday, 06 November 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Siiltibcy...

Read More → news_story
MHRA appoints first Chief Medical and Scientific Officer

MHRA appoints first Chief Medical and Scientific Officer

Tuesday, 04 November 2025

Professor Jacob George has been appointed as the first Chief Medical and Scientific Officer for the Medicines and Healthcare products Regulatory Agenc...

Read More → press_release
Professor Henrietta Hughes: Putting Patient Safety at the Heart of Regulatory Innovation

Professor Henrietta Hughes: Putting Patient Safety at the Heart of Regulatory Innovation

Monday, 03 November 2025

Professor Henrietta Hughes reflects on how MHRA strategy must prioritise patient safety via listening to lived experiences, fostering collaboration & ...

Read More → news_story
MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek

MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek

Monday, 03 November 2025

The tenth annual #MedSafetyWeek brings together more than 130 medicines regulators and health organisations across 117 countries to encourage people t...

Read More → press_release
Major change for rare disease treatments on way, signals MHRA

Major change for rare disease treatments on way, signals MHRA

Sunday, 02 November 2025

New paper sets out UK regulator's intentions to overhaul rulebook for rare disease therapies in UK...

Read More → press_release
Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors

Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors

Friday, 24 October 2025

As with any medicine, the MHRA will keep the safety and effectiveness of concizumab under close review.?...

Read More → news_story
MHRA smashes major?illicit?weight loss medicine production facility in record seizure

MHRA smashes major?illicit?weight loss medicine production facility in record seizure

Friday, 24 October 2025

MHRA strikes massive blow to organised criminal gang in world’s biggest illegal weight loss jabs raid....

Read More → press_release
Side effects from drug interactions to be predicted by AI before reaching patients

Side effects from drug interactions to be predicted by AI before reaching patients

Tuesday, 21 October 2025

The MHRA leads three new government-backed projects using AI-driven approaches to make medicines safer and bring treatments to patients more quickly....

Read More → press_release
AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme

AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme

Thursday, 16 October 2025

Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme....

Read More → press_release
Professor James Levine: When policy becomes medicine

Professor James Levine: When policy becomes medicine

Thursday, 16 October 2025

How regulation can spark life-saving innovation. ...

Read More → news_story
The new Innovative Licensing and Access Pathway welcomes first investigational products

The new Innovative Licensing and Access Pathway welcomes first investigational products

Tuesday, 14 October 2025

Developers work with the NHS, the medicines regulator and the UK health technology assessment bodies from the early stages of clinical development, as...

Read More → press_release
100 years of protecting patients through biological standards for medicines

100 years of protecting patients through biological standards for medicines

Tuesday, 14 October 2025

The MHRA produces over 95 per cent of the World Health Organization’s (WHO) biological standards....

Read More → press_release
Dr Nicola Rose: A new antibiotic is positive news – but it will take more to stay ahead of superbugs

Dr Nicola Rose: A new antibiotic is positive news – but it will take more to stay ahead of superbugs

Sunday, 12 October 2025

The MHRA’s Interim Executive Director of Science and Research writes in The British Medical Journal on the approval of the UK’s first new UTI antibiot...

Read More → news_story
MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule

MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule

Friday, 10 October 2025

Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner....

Read More → news_story
Patients to benefit as UK and US regulators forge new collaboration on medical technologies and AI

Patients to benefit as UK and US regulators forge new collaboration on medical technologies and AI

Tuesday, 07 October 2025

Enhanced collaboration with the US on med tech regulation, with accelerated innovation, strengthened patient safety, and reduced transatlantic barrier...

Read More → press_release
UK clinical trial approval times twice as fast with AI and reforms

UK clinical trial approval times twice as fast with AI and reforms

Monday, 06 October 2025

Patients receive earlier access to life-saving treatments as UK trial approval times cut in half from 91 to just 41 days....

Read More → press_release
MHRA patient safety essay competition 2025

MHRA patient safety essay competition 2025

Sunday, 05 October 2025

The MHRA is inviting the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK....

Read More → press_release
Sir David Spiegelhalter: Regulation in an age of personalised medicine

Sir David Spiegelhalter: Regulation in an age of personalised medicine

Wednesday, 01 October 2025

The internationally renowned expert in the calculation and communication of risk and statistics, Sir David Spiegelhalter, discusses the concept of a ‘...

Read More → news_story
MHRA crackdown on illegal ‘Botox’ after victims left seriously ill

MHRA crackdown on illegal ‘Botox’ after victims left seriously ill

Monday, 29 September 2025

People hospitalised following suspected use of unlicensed botulinum toxin products....

Read More → press_release
MHRA and partners unite to reaffirm prescription weight loss medicine advertising rules

MHRA and partners unite to reaffirm prescription weight loss medicine advertising rules

Friday, 26 September 2025

An updated joint Enforcement Notice provides important clarity on the kinds of claims and images in an ad that are likely to break the rules....

Read More → news_story

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: